These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23948912)

  • 21. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
    Hyde LA; Kazdoba TM; Grilli M; Lozza G; Brusa R; Zhang Q; Wong GT; McCool MF; Zhang L; Parker EM; Higgins GA
    Behav Brain Res; 2005 May; 160(2):344-55. PubMed ID: 15863231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
    Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H
    Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau.
    Hochgräfe K; Sydow A; Matenia D; Cadinu D; Könen S; Petrova O; Pickhardt M; Goll P; Morellini F; Mandelkow E; Mandelkow EM
    Acta Neuropathol Commun; 2015 May; 3():25. PubMed ID: 25958115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice.
    Pennanen L; Wolfer DP; Nitsch RM; Götz J
    Genes Brain Behav; 2006 Jul; 5(5):369-79. PubMed ID: 16879631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
    García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
    J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
    Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
    Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology.
    Sotiropoulos I; Silva J; Kimura T; Rodrigues AJ; Costa P; Almeida OF; Sousa N; Takashima A
    J Alzheimers Dis; 2015; 43(3):763-74. PubMed ID: 25159665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model.
    Orejana L; Barros-Miñones L; Jordán J; Puerta E; Aguirre N
    Neurobiol Aging; 2012 Mar; 33(3):625.e11-20. PubMed ID: 21546125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
    Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
    Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.
    Troquier L; Caillierez R; Burnouf S; Fernandez-Gomez FJ; Grosjean ME; Zommer N; Sergeant N; Schraen-Maschke S; Blum D; Buee L
    Curr Alzheimer Res; 2012 May; 9(4):397-405. PubMed ID: 22272619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Desmercières J; Troquier L; Brouillette J; Tsambou L; Grosjean ME; Caillierez R; Demeyer D; Hamdane M; Schindowski K; Blum D; Buée L
    Curr Alzheimer Res; 2011 Sep; 8(6):633-8. PubMed ID: 21605043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
    Rao SS; Lago L; Volitakis I; Shukla JJ; McColl G; Finkelstein DI; Adlard PA
    Neurotherapeutics; 2021 Apr; 18(2):1081-1094. PubMed ID: 33410108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature control can abolish anesthesia-induced tau hyperphosphorylation and partly reverse anesthesia-induced cognitive impairment in old mice.
    Xiao H; Run X; Cao X; Su Y; Sun Z; Tian C; Sun S; Liang Z
    Psychiatry Clin Neurosci; 2013 Nov; 67(7):493-500. PubMed ID: 23992430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau suppression in a neurodegenerative mouse model improves memory function.
    Santacruz K; Lewis J; Spires T; Paulson J; Kotilinek L; Ingelsson M; Guimaraes A; DeTure M; Ramsden M; McGowan E; Forster C; Yue M; Orne J; Janus C; Mariash A; Kuskowski M; Hyman B; Hutton M; Ashe KH
    Science; 2005 Jul; 309(5733):476-81. PubMed ID: 16020737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model.
    Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J
    Aging Cell; 2017 Apr; 16(2):377-386. PubMed ID: 28160413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.